View in EDS HTML Full Text PDF Full Text

Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.

Saved in:
Bibliographic Details
Title: Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.
Authors: Babu, Suma1 (AUTHOR) sbabu@mgh.harvard.edu, Macklin, Eric A.2 (AUTHOR), Jackson, Katherine E.3 (AUTHOR), Simpson, Elizabeth4 (AUTHOR), Mahoney, Katy1 (AUTHOR), Yu, Hong1 (AUTHOR), Walker, Jason1 (AUTHOR), Simmons, Zachary5 (AUTHOR), David, William S.1 (AUTHOR), Barkhaus, Paul E.6 (AUTHOR), Simionescu, Laura7 (AUTHOR), Dimachkie, Mazen M.8 (AUTHOR), Pestronk, Alan9 (AUTHOR), Salameh, Johnny S.10 (AUTHOR), Weiss, Michael D.11 (AUTHOR), Brooks, Benjamin Rix12 (AUTHOR), Schoenfeld, David2 (AUTHOR), Shefner, Jeremy13 (AUTHOR), Aggarwal, Swati1 (AUTHOR), Cudkowicz, Merit E.1 (AUTHOR)
Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Feb2020, Vol. 21 Issue 1/2, p15-23. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21678421
DOI:10.1080/21678421.2019.1672750